User banner image
User avatar
  • admin

Posts

Anti-Aging Market Expected to Reach USD 2.29 Billion by 2032, Growing at a CAGR of 7.6% From 2024-2032 | Introspective Market Research

Anti Aging Market Size Was Valued at USD 1.18 Billion in 2023 and is Projected to Reach USD 2.29 Billion by 2032, Growing at a...

Blue Diamond Resorts Cuts Check-In Times by 50% with New Online Pre Check-In Feature

ST. MICHAEL, Barbados, Dec. 12, 2024 (GLOBE NEWSWIRE) — Blue Diamond Resorts is revolutionizing the all-inclusive industry with its latest innovation: Online Pre Check-In: Fast...

Cabo Platinum Announces Winners of Best Secret Beaches 2025 in Cabo San Lucas

CABO SAN LUCAS, Mexico, Dec. 12, 2024 (GLOBE NEWSWIRE) — Cabo Platinum, offering premier luxury villas in Cabo San Lucas, is excited to announce the...

Global PCA Zinc Market to Attain Market Size Worth US$ 411.3 Million By 2033 | Astute Analytica

The PCA zinc market flourishes amidst a growing consumer focus on holistic skincare, marrying efficacy and natural ingredients while paving the way for novel product...

HUTCHMED to Receive Milestone Payment from Takeda following First European Reimbursement for FRUZAQLA® (fruquintinib)

— US$10 million milestone payment to HUTCHMED follows first national reimbursement in Europe — — Follows June 2024 European approval of FRUZAQLA® (fruquintinib), the first novel...

Biomea Fusion Announces Oral and Poster Presentations of Icovamenib at the 22nd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)

In preclinical experiments, icovamenib enhanced beta cell function and responsiveness of human islets to GLP-1-based therapies. These effects were associated with an increase in the...

Extendicare Announces December 2024 Dividend of C$0.04 per Share

MARKHAM, Ontario, Dec. 12, 2024 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of...

Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing

Cincinnati, OH, Dec. 12, 2024 (GLOBE NEWSWIRE) — Onconetix, Inc. (NASDAQ: ONCO) (the “Company”) announced that it received a letter from The Nasdaq Capital Market...

Candel Therapeutics Announces $80 Million Proposed Public Offering

NEEDHAM, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (“Candel”) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies...

Mitolyn Unveils New “Purple Peel Exploit” to Support Metabolism and Mitochondrial Health

A Groundbreaking Natural Solution Focused on Mitochondrial Wellness Now Available COLUMBUS, Ohio, Dec. 12, 2024 (GLOBE NEWSWIRE) — Mitolyn, an innovative new dietary supplement, is...